NextFerm Technologies

Non-GMO Yeast Food ingredients

Agriculture & Food Technologies
Public on TASE on Jan, 2021

Company Overview

Snapshot

Founded in December 2013 by Boaz Noy, Tzafra Cohen, Matan Natanson, and Nadav Solomon, NextFerm Technologies operates with 11–50 employees. The company has raised $19.18M across three funding rounds from two investors. NextFerm Technologies went public on the TASE in January 2021.

Business overview

NextFerm Technologies focuses on developing, manufacturing, and marketing novel active ingredients derived from non-GMO yeast fermentation and extraction processes. Its flagship product, Protevin, is a neutral-tasting, nutritional protein produced sustainably and cost-effectively, primarily for dairy and powder pre-mixes. The company also offers AstaFerm. NextFerm Technologies serves the food and beverage industry, operating within the agriculture and food technologies sector, with a focus on novel food and ingredients, alternative proteins, and sustainable proteins.

Strategic signal

In April 2025, NextFerm Technologies suspended operations due to an inability to pay debts and is actively seeking a buyer. This indicates a critical financial challenge and a potential restructuring or acquisition in the near future, signaling significant risk for investors.

Company Intelligence Q&A

What is ProteVin?
ProteVin is NextFerm Technologies' leading product, a vegan protein derived from non-GMO yeast fermentation. It is designed to have a neutral taste and nutritional profile, suitable for various applications, particularly in dairy and powder pre-mixes.
When did NextFerm Technologies go public?
NextFerm Technologies completed its Initial Public Offering on the TASE in January 2021.
What was a significant commercial milestone for ProteVin in the US market?
In June 2022, NextFerm Technologies announced its first commercial delivery of ProteVin in the U.S., marking a key step in its market expansion.
What strategic manufacturing agreement did NextFerm Technologies announce in July 2023?
In July 2023, NextFerm Technologies announced a commercial manufacturing agreement for the production of ProteVin with Kothari Fermentation and Biochem, a subcontractor in India.
What is the current operational status of NextFerm Technologies?
In April 2025, NextFerm Technologies suspended operations because it could not pay its debts and is currently seeking a buyer.

External links